Thus, lipid metabolic remodeling, particularly via ACSL4 modifications and mevalonate pathway activation, serves as a decisive determinant of ferroptotic vulnerability in NPC. The gene discussed is ACSL4; the disease is nasopharyngeal carcinoma.